The role of 18F-FDG PET/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw
Conclusion: For predicting occurrence of MRONJ, the threshold of SUVmax = 5.2 in the jaw may be used. A differential diagnosis including MRONJ is recommended when we incidentally detect regions with high 18F-FDG uptake in the jaw during routine oncologic surveillance. Research Support:
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Watanabe, S., Nakajima, K., Inokuchi, M., Noguchi, N., Kawashiri, S., Mizokami, A., Kinuya, S. Tags: Musculoskeletal Source Type: research
More News: Avastin | Breast Cancer | Cancer | Cancer & Oncology | CT Scan | Dentistry | Nuclear Medicine | Oral Cancer | PET Scan | Reclast | Study | Xgeva | Zometa